Fentanyl by Continuous Subcutaneous Infusion for the Management of Cancer Pain: A Retrospective Study
- 30 November 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 16 (5) , 323-326
- https://doi.org/10.1016/s0885-3924(98)00095-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain managementPain, 1995
- Opioid rotation for toxicity reduction in terminal cancer patientsJournal of Pain and Symptom Management, 1995
- Day-to-day titration of transdermal fentanyl is unwiseSupportive Care in Cancer, 1995
- Guidelines for the clinical use of transdermal fentanylAnti-Cancer Drugs, 1995
- Transdermal Fentanyl for Cancer Pain Repeated Dose PharmacokineticsAnesthesiology, 1993
- Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer painThe Lancet, 1991
- The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effectsPain, 1989
- The Treatment of Cancer PainNew England Journal of Medicine, 1985
- Clinical Pharmacokinetics of Fentanyl and its Newer DerivativesClinical Pharmacokinetics, 1983
- “Mini-mental state”Journal of Psychiatric Research, 1975